Chaitanya Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 8.50 M
as on 15-11-2024
- Paid Up Capital ₹ 4.46 M
as on 15-11-2024
- Company Age 38 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.35 Cr
as on 15-11-2024
- Satisfied Charges ₹ 3.38 Cr
as on 15-11-2024
- Revenue 15.13%
(FY 2023)
- Profit -13.65%
(FY 2023)
- Ebitda -6.48%
(FY 2023)
- Net Worth 4.69%
(FY 2023)
- Total Assets 6.91%
(FY 2023)
About Chaitanya Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.50 M and a paid-up capital of Rs 4.46 M.
The company currently has active open charges totaling ₹4.35 Cr. The company has closed loans amounting to ₹3.38 Cr, as per Ministry of Corporate Affairs (MCA) records.
Uday Kulkarni, Kishor Shah, Pushkar Pathak, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24230MH1986PTC039999
- Company No.
039999
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jun 1986
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Chaitanya Pharmaceuticals Pvt Ltd offer?
Chaitanya Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Pain Killers, Cough Syrup, Ayurvedic Medicine, Ayurvedic Kidney Medicine, Juices, Soups & Soft Drinks, Drinking Water, Pharmaceutical Medicine, Herbal Piles Medicine, Herbal Piles Capsules and Tablets.
Who are the key members and board of directors at Chaitanya Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pushkar Pathak  | Managing Director | 22-Sep-2007 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Uday Kulkarni | Director | 21-Sep-2002 | Current |
| Kishor Shah | Director | 17-Dec-2002 | Current |
| Govind Joshi | Director | 21-Sep-2002 | Current |
| Nilkanth Pandit | Director | 21-Sep-2002 | Current |
| Sharad Pathak | Director | 21-Sep-2002 | Current |
| Shilpa Pathak | Director | 21-Sep-2002 | Current |
Financial Performance of Chaitanya Pharmaceuticals.
Chaitanya Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 15.13% increase. The company also saw a substantial fall in profitability, with a 13.65% decrease in profit. The company's net worth moved up by a moderate rise of 4.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chaitanya Pharmaceuticals?
In 2022, Chaitanya Pharmaceuticals had a promoter holding of 74.04% and a public holding of 25.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 31 Oct 2023 | ₹1.00 Cr | Open |
Axis Bank Limited Creation Date: 08 Jan 2020 | ₹2.00 Cr | Open |
Axis Bank Limited Creation Date: 08 Jan 2020 | ₹3.50 M | Open |
How Many Employees Work at Chaitanya Pharmaceuticals?
Unlock and access historical data on people associated with Chaitanya Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chaitanya Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chaitanya Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
